Fetal sex and the relative reactivity of human umbilical vein and arteries are key determinants in potential beneficial effects of phosphodiesterase inhibitors
Open Access
- 1 June 2024
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 136 (6) , 1526-1545
Abstract
The effects of phosphodiesterase inhibition on the umbilical circulation depend on the presence of intrauterine growth restriction, the fetal sex, vessel type, and vasoconstrictors implicated. The human umbilical vascular tone regulation is complex and depends on the amount and activity of specific proteins but also probably on the subcellular organization mediating protein interactions. Therefore, therapeutic interventions using phosphodiesterase inhibitors to improve the placental-fetal circulation should consider fetal sex and both umbilical vein and artery reactivity.Keywords
Funding Information
- Swiss National Science Foundation (32003B_138491)
- W. and E. Grand d'Hauteville for Academic Biomedical and Nursing Research
This publication has 42 references indexed in Scilit:
- Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER studyEuropean Journal of Pediatrics, 2022
- Differential Distribution of Tryptophan-Metabolites in Fetal and Maternal Circulations During Normotensive and Preeclamptic PregnanciesReproductive Sciences, 2021
- Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth RestrictionJAMA Network Open, 2020
- Consensus Based Definition of Growth Restriction in the NewbornThe Journal of Pediatrics, 2018
- Physiological adaptation of the growth-restricted fetusBest Practice & Research Clinical Obstetrics & Gynaecology, 2018
- The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restrictionAmerican Journal of Obstetrics and Gynecology, 2018
- Cyclic guanosine monophosphate compartmentation in human vascular smooth muscle cellsCellular Signalling, 2015
- Prostanoid TP receptor-mediated impairment of cyclic AMP-dependent vasorelaxation is reversed by phosphodiesterase inhibitorsEuropean Journal of Pharmacology, 2010
- PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteriesEuropean Journal of Pharmacology, 2008
- Human umbilical vessels: Responses to agents frequently used in obstetric patientsAmerican Journal of Obstetrics and Gynecology, 1995